Estonia - Sold Production of Medicaments Containing Corticosteroid Hormones, Their Derivatives and Structural Analogues, Put Up in Measured Doses or for Retail Sale
Since 2014, Estonia Sold Production of Medicaments Containing Corticosteroid Hormones, Their Derivatives and Structural Analogues, Put Up in Measured Doses or for Retail Sale rose 19.6% year on year. With €2,003,910 in 2019, the country was number 16 among other countries in Sold Production of Medicaments Containing Corticosteroid Hormones, Their Derivatives and Structural Analogues, Put Up in Measured Doses or for Retail Sale. Denmark lead the ranking with €3,801,340,964.3 in 2019, that is -2.9% versus 2018. Belgium, Italy and Germany respectively ranked number 2, 3 and 4 in this ranking. Italy recorded the best 5 years average growth at +51.7% per year, while Netherlands recorded the worst performance at -13.4% per year.
Loading...
Date | Euros |
---|---|
2019 | 2,003,910.00 |
2018 | 1,648,213.00 |
2017 | 2,661,503.00 |
2016 | 1,751,202.00 |
2015 | 1,056,833.00 |
How does Estonia rank in Sold Production of Medicaments Containing Corticosteroid Hormones, Their Derivatives and Structural Analogues, Put Up in Measured Doses or for Retail Sale?
# | 16 Countries | Euros | Last | YoY | 5‑years CAGR | ||
---|---|---|---|---|---|---|---|
1 |
#1
Denmark
|
3,801,340,964.30 | 2019 | -2.9 % | +26.5 % | View data | |
2 |
#2
Belgium
|
1,624,727,500.00 | 2018 | +46.2 % | NA | View data | |
15 |
#15
Macedonia
|
5,522,929.00 | 2019 | -1.5 % | +13.5 % | View data | |
16 |
#16
Estonia
|
2,003,910.00 | 2019 | +21.6 % | +19.6 % | View data |